Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer

Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer

Bibliographic Details
Main Authors:	Wassila Khatir, Olivier Humbert, Jonathan Benzaquen, Christophe Bontoux, Jaap Neels, Léa Berland, Fabian Andrés Gallardo Rivera, Maryline Allegra, Myriam Salah, Virginie Tanga, Olivier Bordone, Julien Fayada, Virginie Lespinet‐Fabre, Doriane Bohly, Elodie Long‐Mira, Sandra Lassalle, Valérie Vouret, Patrick Brest, Baharia Mograbi, Charlotte Maniel, Josiane Otto, Jacques Boutros, Simon Heeke, Véronique Hofman, Charles‐Hugo Marquette, Paul Hofman, Marius Ilié
Format:	Article
Language:	English
Published:	Wiley 2022-08-01
Series:	Clinical and Translational Medicine
Online Access:	https://doi.org/10.1002/ctm2.1018

Similar Items

Evaluation of Sample Pooling for SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples with the Idylla SARS-CoV-2 Test
by: Paul Hofman, et al.
Published: (2021-12-01)

Setting-Up a Rapid SARS-CoV-2 Genome Assessment by Next-Generation Sequencing in an Academic Hospital Center (LPCE, Louis Pasteur Hospital, Nice, France)
by: Paul Hofman, et al.
Published: (2022-01-01)

Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)
by: Marius Ilié, et al.
Published: (2022-04-01)

Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution
by: Simon Heeke, et al.
Published: (2020-02-01)

Salivary detection of COVID-19: clinical performance of oral sponge sampling for SARS-CoV-2 testing
by: Jacques Boutros, et al.
Published: (2021-12-01)

Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens
by: Marius Ilié, et al.
Published: (2023-02-01)

Targeted Assessment of the <i>EGFR</i> Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)
by: Sandra Lassalle, et al.
Published: (2020-04-01)

Daily Practice Assessment of <i>KRAS</i> Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner
by: Christophe Bontoux, et al.
Published: (2022-03-01)

Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients
by: Simon Heeke, et al.
Published: (2018-03-01)

Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank
by: Arnaud Martel, et al.
Published: (2023-04-01)

The Importance of <i>STK11</i>/<i>LKB1</i> Assessment in Non-Small Cell Lung Carcinomas
by: Baharia Mograbi, et al.
Published: (2021-01-01)

Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing
by: Nina Pujol, et al.
Published: (2022-10-01)

Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment
by: Simon Heeke, et al.
Published: (2019-07-01)

Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System
by: Simon Heeke, et al.
Published: (2021-04-01)

In-house Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-small Cell Lung Cancer and Melanoma Patients
by: Simon Heeke, et al.
Published: (2019-08-01)

Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?
by: Jonathan Benzaquen, et al.
Published: (2019-06-01)

Deciphering the Impact of <i>HER2</i> Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches
by: Christophe Bontoux, et al.
Published: (2022-10-01)

Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice
by: Arnaud Martel, et al.
Published: (2023-07-01)

The Need to Set up a Biobank Dedicated to Lymphoid Malignancies: Experience of a Single Center (Laboratory of Clinical and Experimental Pathology, University Côte d’Azur, Nice, France)
by: Christophe Bontoux, et al.
Published: (2023-06-01)

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?
by: Véronique Hofman, et al.
Published: (2018-03-01)

Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images
by: Marius Ilié, et al.
Published: (2022-03-01)

Lung Cancer Screening, towards a Multidimensional Approach: Why and How?
by: Jonathan Benzaquen, et al.
Published: (2019-02-01)

Subversion of autophagy in adherent invasive Escherichia coli-infected neutrophils induces inflammation and cell death.
by: Abderrahman Chargui, et al.
Published: (2012-01-01)

Comparison of Two Rapid Assays for the Detection of <i>BRAF</i> V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes
by: Elodie Long-Mira, et al.
Published: (2022-03-01)

Circulating Tumor Cell Detection in Lung Cancer: But to What End?
by: Véronique Hofman, et al.
Published: (2019-02-01)

The Purinergic Landscape of Non-Small Cell Lung Cancer
by: Serena Janho dit Hreich, et al.
Published: (2022-04-01)

Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA
by: Kevin Washetine, et al.
Published: (2018-06-01)

A Real-World Experience from a Single Center (LPCE, Nice, France) Highlights the Urgent Need to Abandon Immunohistochemistry for ROS1 Rearrangement Screening of Advanced Non-Squamous Non-Small Cell Lung Cancer
by: Véronique Hofman, et al.
Published: (2023-05-01)

Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives
by: Arnaud Martel, et al.
Published: (2020-11-01)

The Carcinogen Cadmium Activates Lysine 63 (K63)-Linked Ubiquitin-Dependent Signaling and Inhibits Selective Autophagy
by: Abderrahman Chargui, et al.
Published: (2021-05-01)

A case report of exogenous lipoid pneumonia associated with avocado/soybean unsaponifiables
by: Jacques BOUTROS, et al.
Published: (2019-12-01)

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?
by: Kevin Washetine, et al.
Published: (2018-06-01)

Multidisciplinary management of tracheobronchial injury
by: Jacques Boutros, et al.
Published: (2022-01-01)

The Role of IL-18 in P2RX7-Mediated Antitumor Immunity
by: Serena Janho dit Hreich, et al.
Published: (2023-05-01)

Prognostic Role of <i>KRAS G12C</i> Mutation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
by: Durgesh Wankhede, et al.
Published: (2023-09-01)

Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC.
by: Céline Sanfiorenzo, et al.
Published: (2013-01-01)

KRAS and NRAS Translation Is Increased upon MEK Inhibitors-Induced Processing Bodies Dissolution
by: Olivia Vidal-Cruchez, et al.
Published: (2023-06-01)

Protocol for Evaluating In Vivo the Activation of the P2RX7 Immunomodulator
by: Serena Janho dit Hreich, et al.
Published: (2023-01-01)

Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer—Just About Ready for Prime-Time?
by: Paul Hofman, et al.
Published: (2019-02-01)

ORENZA: a web resource for studying ORphan ENZyme activities
by: Labedan Bernard, et al.
Published: (2006-10-01)